UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

The New England journal of medicine, 2019-11, Vol.381 (21), p.2020-2031

2019

Link zum Volltext

Verfügbarkeit prüfen

The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma

European journal of cardio-thoracic surgery, 2004-04, Vol.25 (4), p.497-501

2004

Link zum Volltext

Verfügbarkeit prüfen

Platinum-based chemotherapy in metastatic breast cancer: current status

Cancer treatment reviews, 2004-02, Vol.30 (1), p.53-81

2004

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in patients with advanced non-small cell lung cancer: Data from the phase III FLEX study

Lung cancer (Amsterdam, Netherlands), 2012-08, Vol.77 (2), p.376-382

2012

Link zum Volltext

Verfügbarkeit prüfen

VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC

Annals of oncology, 2024-01, Vol.35 (1), p.142-144

2024

Link zum Volltext

Verfügbarkeit prüfen

Carbonic Anhydrase IX Expression and Outcome after Radiotherapy for Muscle-invasive Bladder Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2007-12, Vol.19 (10), p.777-783

2007

Link zum Volltext

Verfügbarkeit prüfen

AIDS-related Kaposi's Sarcoma in a Patient with a Normal CD4 Count

Clinical oncology (Royal College of Radiologists (Great Britain)), 2008-02, Vol.20 (1), p.97-97

2008

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

The New England journal of medicine, 2018-05, Vol.378 (22), p.2093-2104

2018

Link zum Volltext

Verfügbarkeit prüfen

The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease

European Journal of Cancer, 2000-01, Vol.36 (2), p.151-169

2000

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer

Annals of oncology, 2008-02, Vol.19 (2), p.362-369

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis

Annals of oncology, 2023-02, Vol.34 (2), p.173-185

2023

Link zum Volltext

Verfügbarkeit prüfen

Herceptest: Her2 expression and gene amplification in non‐small cell lung cancer

International journal of cancer, 2001-05, Vol.92 (4), p.480-483

2001

Link zum Volltext

Verfügbarkeit prüfen

CA-125 criteria for response evaluation in ovarian cancer

Gynecologic oncology, 2005-09, Vol.98 (3), p.520-521

2005

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (3), p.169-177

2000

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study

European journal of cancer (1990), 2000-12, Vol.36 (18), p.2329-2334

2000

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial

ESMO open, 2023-12, Vol.8 (6), p.102065-102065, Article 102065

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy

Gynecologic oncology, 2004-08, Vol.94 (2), p.502-508

2004

Link zum Volltext

Verfügbarkeit prüfen

EGFR expression: Associations with outcome and clinicopathological variables in malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2006-12, Vol.54 (3), p.399-407

2006

Link zum Volltext

Verfügbarkeit prüfen

Platinum-based Chemotherapy in Metastatic Breast Cancer: The Leicester (UK) Experience

Clinical oncology (Royal College of Radiologists (Great Britain)), 2005-06, Vol.17 (4), p.249-257

2005

Link zum Volltext

Verfügbarkeit prüfen

Towards a biological staging model for operable non-small cell lung cancer

Lung cancer, 2001-12, Vol.34, p.S83-S89

2001

Link zum Volltext

Verfügbarkeit prüfen

Endothelin-1 is a novel prognostic factor in non-small cell lung cancer

The International journal of biological markers, 2004-10, Vol.19 (4), p.262-267

2004

Link zum Volltext

Verfügbarkeit prüfen

Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies

European journal of cancer (1990), 2006-09, Vol.42 (14), p.2318-2325

2006

Link zum Volltext

Verfügbarkeit prüfen

The use of microvessel density in assessing human urological tumours

BJU international, 2001-06, Vol.87 (9), p.866-875

2001

Link zum Volltext

Verfügbarkeit prüfen

Angiogenesis and non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2000-02, Vol.27 (2), p.81-100

2000

Link zum Volltext

Verfügbarkeit prüfen

Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2005-04, Vol.48 (1), p.47-57

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(3)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma

Platinum-based chemotherapy in metastatic breast cancer: current status

Prognostic factors in patients with advanced non-small cell lung cancer: Data from the phase III FLEX study

VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC

Carbonic Anhydrase IX Expression and Outcome after Radiotherapy for Muscle-invasive Bladder Cancer

AIDS-related Kaposi's Sarcoma in a Patient with a Normal CD4 Count

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer

Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis

Herceptest: Her2 expression and gene amplification in non‐small cell lung cancer

CA-125 criteria for response evaluation in ovarian cancer

Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study

Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial

Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy

EGFR expression: Associations with outcome and clinicopathological variables in malignant pleural mesothelioma

Platinum-based Chemotherapy in Metastatic Breast Cancer: The Leicester (UK) Experience

Towards a biological staging model for operable non-small cell lung cancer

Endothelin-1 is a novel prognostic factor in non-small cell lung cancer

Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies

The use of microvessel density in assessing human urological tumours

Angiogenesis and non-small cell lung cancer

Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer

Aktive Filter

Suchergebnisse filtern